Conference Registration & Agenda

Conference Secretariat
ICAA 1996 Amsterdam
c/o Amsterdam RAI-OBA
POB 7777
1070 MS Amsterdam
The Netherlands
tel: 31 (0)20 549 12 12
fax: 31 (0)20 646 44 69

Local Organizer

Jellinek Clinic
Amsterdam

Ibogaine information

NDA International, Inc.
POB 100506
Staten Island, NY 10310
USA
email: ibogaine@desk.nl
fax : 1-718-442-1957
WWW : http://www.desk.nl/~ibogaine/

SUPPRESSANT EFFECTS OF IBOGAINE AND ITS PRIMARY METABOLITE ON ALCOHOL INTAKE IN THREE STRAINS OF ALCOHOL PREFERRING RATS
Amir H. Rezvani, D.C. Mash, W.L. Hearn, D.H. Overstreet, Y.W. Lee, Center for Alcohol Studies and Department of Psychiatry, University of North Carolina School of Medicine Chapel Hill, Chappel Hill, NC 27599-7178, USA.

MECHANISM OF ANTI-ADDICTIVE ACTIONS OF IBOGAINE
Stanley D. Glick, Isabelle M. Maisonneuve and Sandra M. Pearl, Department of Pharmacology and Neuroscience, Albany Medical College, A-136, 47 New Scotland Ave., Albany, NY 12208, USA.

IBOGAINE, TRAUMA AND ABREACTION IN THE TREATMENT OF CHEMICAL DEPENDENCE
H.S. Lotsof, NDA International, Inc., POB 100506, Staten Island, NY 10310-0506, USA; C.A. Smith F., Chairman, Republic of Panama Chapter, American Society of Addiction Medicine (ASAM); Prof. dr. J. Bastiaans, Oegstgeest, The Netherlands (retired).

NEUROLOGIC AND EEG OBSERVATIONS IN SUBJECTS ADMINISTERED IBOGAINE
Daniel Luciano, Director, Clinical Epilepsy Program, Hospital for Joint Diseases / New York University School of Medicine, Orthopaedic Institute, Rm 1229, 301 E 17th Street, New York, NY 10003, USA; Ezdquiel Jethmal G., Centro Medico Paitilla, Panama City, Republic of Panama; Edgardo A Della Sera, Ministry of Health, Republic of Panama, POB 447, David, Chiriqui, Republic of Panama.

STRUCTURALLY MODIFIED ANALOGUES OF IBOGAINE EXHIBIT DIFFERING AFFINITIES FOR NMDA RECEPTORS: IMPLICATIONS FOR ITS PUTATIVE ANTI-ADDICTIVE PROPERTIES
Richard T. Layer, Phil Skolnick, Craid M. Bertha, Martin E. Kuehne and Piotr Popik*, Laboratory of Neuroscience, NIDK, NIH, Bethesda, MD 10892, USA. *Institut of Pharmacology, Polish Academy of Science, Smetna 12, 31-343, Krakow, Poland

IBOGAINE:

A New Treatment Modality To Interrupt Chemical Dependence

International Scientific Ibogaine Presentations
40th International Institute for the Prevention and Treatment of Dependencies
Amsterdam, The Netherlands
30 June - 5 July 1996

OVERVIEW:

Ibogaine, a substance discovered in plants from the West African rain forests has been reported to reduce both narcotic and cocaine withdrawal symptoms while concurrently precipitating a process of abreaction that attenuates or interrupts the craving to use drugs of high abuse potential.

Ibogaine is equally effective in the elimination of withdrawal signs for both short acting narcotics such as heroin, or longer acting opioids such as Methadone. The Ibogaine treatment procedure consists of a single oral administration and is generally completed in four days. One of Ibogaine's interesting attributes is its ability to reveal and affect the underlying trauma that may have lead to self medicating and drug misuse. Ibogaine appears to precipitate the release of repressed memories providing the patient vital information and the clarity to analyze the reasons for their chemical dependence and most important, to admit that they require the assistance of adjunct therapy to modify their drug seeking behavior.

Mr. Lotsof will be available to meet with clinic directors and government health officials interested in providing Ibogaine (ENDABUSE TM) treatments in clinical facilities. Preliminary information on Ibogaine can be obtained at http://www.desk.nl/~ibogaine.

MAPS Home Page